Prevalence and risk factors for venous thromboembolic events in critically ill patients with SARS-CoV-2 infection: a prospective observational study

A year in review in Minerva Anestesiologica 2019. Critical care

“…22 according to a study by chiesa et al published in December, 41% of critically ill, mechanically ventilated coViD-19 patients developed deep venous thrombosis, the majority being catheter-related and occurring under pharmacologic thromboprophylaxis. 23 of note, an initial strategy of therapeutic anticoagulation with heparin does not increase the probability of survival of hensive score to assess the initial lung involvement in 85 coViD-19 patients; they reported that the score was a good predictor of the need for mechanical ventilation and NiV failure. 8 treatment with low-dose dexamethasone and tocilizumab, a humanized monoclonal antibody against the il-6 receptor, may decrease mortality among coViD-19 patients receiving mechanical ventilation.…”